These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pyloric obstruction caused by aspirin: case report. Sherry E N Z Med J; 1979 Mar; 89(631):174-5. PubMed ID: 287936 [TBL] [Abstract][Full Text] [Related]
3. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs. Takada M; Fukumoto K; Shibakawa M J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408 [TBL] [Abstract][Full Text] [Related]
4. [Gastric retention and enteric-coated tablets]. Eikeland O Tidsskr Nor Laegeforen; 1978 Feb; 98(6):306-7. PubMed ID: 635860 [No Abstract] [Full Text] [Related]
6. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration. Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315 [TBL] [Abstract][Full Text] [Related]
7. Interaction of omeprazole with enteric-coated salicylate tablets. Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060 [TBL] [Abstract][Full Text] [Related]
8. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability. Portek I; Graham G; Fleming A Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303 [TBL] [Abstract][Full Text] [Related]
9. Enteric-coated aspirin and the problem of gastric retention. Baum J J Rheumatol; 1984 Apr; 11(2):250-1. PubMed ID: 6726728 [No Abstract] [Full Text] [Related]
10. [Experimental study on the gastric tolerance of aspirin in coated particles]. Lechat P; Ganter P; Fontagné J; Flouvat B Therapie; 1967; 22(2):403-10. PubMed ID: 6063428 [No Abstract] [Full Text] [Related]
13. Single-dose evaluation of a new enteric-coated aspirin preparation. Page M Med J Aust; 1976 Jul; 2(2):74. PubMed ID: 979806 [No Abstract] [Full Text] [Related]
14. The microspherule concept of enteric coated salicylates. Tillis HH J Med Soc N J; 1966 Sep; 63(9):416-7. PubMed ID: 5231803 [No Abstract] [Full Text] [Related]
15. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level]. Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511 [TBL] [Abstract][Full Text] [Related]
16. Enteric coated aspirin. Grossman CM Am J Med; 2007 Apr; 120(4):e9. PubMed ID: 17398216 [No Abstract] [Full Text] [Related]
17. Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? Walker J; Robinson J; Stewart J; Jacob S Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):519-22. PubMed ID: 17669925 [TBL] [Abstract][Full Text] [Related]
18. Aspirin. Scopp IW; Roehrl PL N Y J Dent; 1979; 49(7):218-20. PubMed ID: 287960 [No Abstract] [Full Text] [Related]
19. Tablets of coated aspirin microspherules--a new dosage form. Green DM J New Drugs; 1966; 6(5):294-304. PubMed ID: 5339421 [No Abstract] [Full Text] [Related]
20. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets. Paton TW; Walker SE; Leung FY; Little AH Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946 [No Abstract] [Full Text] [Related] [Next] [New Search]